Summit Therapeutics Shares Fall 21% After Late-Stage Lung Cancer Treatment Data
Summit Therapeutics Shares Fall 21% After Late-Stage Lung Cancer Treatment Data
晚期肺癌治療數據公佈後，Summit Therapeutics股價下跌21％
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊